These findings provide evidence for the activation of the FGD5-AS1/miR-15a-5p/BHLHE40 axis during pancreatic cancer pathogenesis in vivo and its close association with tumor growth. This evidence concerns the gene FGD5 and familial pancreatic carcinoma.